Larimar Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LRMR and other ETFs, options, and stocks.

About LRMR

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia.

CEO

Carole S. Ben-Maimon

CEOCarole S. Ben-Maimon

Employees

Employees65

Headquarters

Bala Cynwyd, Pennsylvania

HeadquartersBala Cynwyd, Pennsylvania

Founded

2005

Founded2005

Employees

Employees65

LRMR Key Statistics

Market cap

205.86M

Market cap205.86M

Price-Earnings ratio

-2.31

Price-Earnings ratio-2.31

Dividend yield

—

Dividend yield—

Average volume

778.57K

Average volume778.57K

High today

$3.55

High today$3.55

Low today

$3.11

Low today$3.11

Open price

$3.51

Open price$3.51

Volume

853.44K

Volume853.44K

52 Week high

$11.20

52 Week high$11.20

52 Week low

$1.61

52 Week low$1.61

Analyst ratings

100%

of 11 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own LRMR. This list is generated using Robinhood data, and it’s not a recommendation.

Larimar Therapeutics

Why Robinhood?

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. Show more

LRMR Key Statistics

Analyst ratings

100%

People also own

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia.